COVID Vaccine Trials Move at Warp Speed, But Recruiting Black Volunteers Takes Time
The National Institutes of Health has suggested minorities should be overrepresented in COVID-19 vaccine trials — perhaps at rates that are double their percentage of the U.S. population. But efforts to recruit patients from racial minority groups are just beginning, while some trials have already advanced to phase 3.
Los NIH, “muy preocupados” por efectos secundarios en ensayo de vacuna para COVID
La Administración de Alimentos y Medicamentos está evaluando la posibilidad de seguir a los reguladores británicos y reanudar el ensayo de la vacuna. Pero hay dudas.
NIH ‘Very Concerned’ About Serious Side Effect in Coronavirus Vaccine Trial
The AstraZeneca trial is on hold in the U.S. as scientists try to unravel whether a rare neurological condition is linked to the vaccine. But regulators are frustrated by a lack of information from the drugmaker.
Readers and Tweeters Grapple With COVID Therapies and Forecasts
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
KHN’s ‘What the Health?’: The Politics of Science
Republicans have all but abandoned the Affordable Care Act as a campaign cudgel, judging from their national convention, at least. Meanwhile, career scientists at the federal government’s preeminent health agencies — the Food and Drug Administration, the Centers for Disease Control and Prevention and the National Institutes of Health — are all coming under increasing political pressure as the pandemic drags on. Joanne Kenen of Politico, Mary Ellen McIntire of CQ Roll Call and Sarah Karlin-Smith of the Pink Sheet join KHN’s Julie Rovner to discuss this and more. Plus, Rovner interviews KHN’s Elizabeth Lawrence about the latest KHN-NPR “Bill of the Month” installment.
Most Adults Wary of Taking Any Vaccine Approved Before the Election
About 60% of poll respondents are worried that federal regulators will rush to allow a vaccine because of political pressure. Opposition to getting a vaccine that might be authorized before the November election is strongest among Republicans.
Con la escuela virtual… ¿qué pasa con las vacunas obligatorias?
Las escuelas juegan un papel fundamental en los esfuerzos de vacunación en los Estados Unidos. Ahora el desafío es mantener la inmunización con la instrucción a distancia.
With Schools Starting Online, Vaccinations Head for Recess
Traditionally, requirements that kids undergo certain immunizations before attending school have been a critical public health tool. Health officials are scrambling to make sure children don’t fall through the cracks.
As Threat of Valley Fever Grows Beyond the Southwest, Push Is On for Vaccine
Efforts are underway to bring to market a vaccine for valley fever, a fungal infection with COVID-like symptoms that occurs in the deserts of the Southwest. The illness is getting more attention as cases rise and a warming climate threatens to spread it through the West.
Oficiales de salud temen que el país no esté listo para una vacuna contra COVID-19
El camino para entregar vacunas a 330 millones de personas sigue sin estar claro para los funcionarios de salud locales que, se espera, sean los que realicen el trabajo.
Health Officials Worry Nation’s Not Ready for COVID-19 Vaccine
As the nation awaits a vaccine to end the pandemic, local health departments say they lack the staff, money, tools ― and a unified plan ― to distribute, administer and track millions of vaccines, most of which will require two doses. Dozens of doctors, nurses and health officials interviewed by KHN and The Associated Press expressed their concern and frustration over federal shortcomings.
Fauci Says COVID Vaccine Trials Could End Early If Results Are Overwhelming
The nation’s top infectious disease official is confident that an independent panel will base vaccine approval on science, not politics.
Fauci dice que una vacuna contra COVID podría estar lista antes de lo esperado
El experto en enfermedades infecciosas de más alto rango en el país dice que esto podría ocurrir si los ensayos clínicos en curso producen resultados abrumadoramente positivos.
COVID + Influenza: éste es un buen año para vacunarse, aconsejan expertos
Con el país en medio de una pandemia, expertos dicen que nadie sabe qué sucedería si se contrae influenza y COVID simultáneamente porque nunca ocurrió antes.
Republican Convention, Day 4: Fireworks … and Shining a Light on Trump’s Claims
Donald Trump accepted his party’s nomination to seek reelection for a second term as president in front of a partisan audience that appeared to largely lack masks and opt against social distancing.
COVID + Influenza: This Is a Good Year to Get a Flu Shot, Experts Advise
A robust sign-up for flu shots could help head off a nightmare scenario in the coming winter of hospitals stuffed with both COVID-19 patients and those suffering from severe effects of influenza. Plus, no one knows how flu and COVID might interact if a patient got both.
LA Hospital Seeks Vaccine Trial Participants Among Its Own High-Risk Patients
Harbor-UCLA Medical Center serves patients who are especially vulnerable to the coronavirus: They are essential workers, have chronic diseases and are members of underrepresented racial and ethnic groups. When the safety-net hospital kicks off enrollment for its COVID-19 vaccine trial Wednesday, it will look to those patients to participate.
They Pledged to Donate Rights to Their COVID Vaccine, Then Sold Them to Pharma
Advocates of cheap and widely available vaccines thought the pandemic might change business as usual. They were wrong.
Confianza, miedo y solidaridad marcarán el éxito de una vacuna contra COVID
Cuando una vacuna contra el coronavirus esté disponible, ¿la recibirán con una gran ovación, como la vacuna contra la polio, o con cierto letargo, como la vacuna contra el sarampión?
Trust, Fear and Solidarity Will Determine the Success of a COVID Vaccine
Polio terrified Americans, and in 1955, when Jonas Salk’s vaccine became available, they snapped it up like candy. Sixty-five years later, COVID is the latest dread virus, but many undercurrents could inhibit its acceptance.
